Literature DB >> 10452889

Gene organisation, sequence variation and isochore structure at the centromeric boundary of the human MHC.

R Stephens1, R Horton, S Humphray, L Rowen, J Trowsdale, S Beck.   

Abstract

We have mapped and sequenced the region immediately centromeric of the human major histocompatibility complex (MHC). A cluster of 13 genes/pseudogenes was identified in a 175 kb PAC linking the TAPASIN locus with the class II region. It includes two novel human genes (BING4 and SACM2L) and a thus far unnoticed human leucocyte antigen (HLA) class II pseudogene, termed HLA-DPA3. Analysis of the G+C content revealed an isochore boundary which, together with the previously reported telomeric boundary, defines the MHC class II region as one of the first completely sequenced isochores in the human genome. Comparison of the sequence with limited sequence from other cell lines shows that the high sequence variation found within the classical class II region extends beyond the identified isochore boundary leading us to propose the concept of an "extended MHC". By comparative analysis, we have precisely identified the mouse/human synteny breakpoint at the centromeric end of the extended MHC class II region between the genes HSET and PHF1. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452889     DOI: 10.1006/jmbi.1999.3004

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  11 in total

1.  IsoFinder: computational prediction of isochores in genome sequences.

Authors:  José L Oliver; Pedro Carpena; Michael Hackenberg; Pedro Bernaola-Galván
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

2.  An isochore transition in the NF1 gene region coincides with a switch in the extent of linkage disequilibrium.

Authors:  I Eisenbarth; G Vogel; W Krone; W Vogel; G Assum
Journal:  Am J Hum Genet       Date:  2000-09-06       Impact factor: 11.025

3.  Identification of BING-4 cancer antigen translated from an alternative open reading frame of a gene in the extended MHC class II region using lymphocytes from a patient with a durable complete regression following immunotherapy.

Authors:  Steven A Rosenberg; Panida Tong-On; Yong Li; John P Riley; Mona El-Gamil; Maria R Parkhurst; Paul F Robbins
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

4.  Characterization of clustered MHC-linked olfactory receptor genes in human and mouse.

Authors:  R M Younger; C Amadou; G Bethel; A Ehlers; K F Lindahl; S Forbes; R Horton; S Milne; A J Mungall; J Trowsdale; A Volz; A Ziegler; S Beck
Journal:  Genome Res       Date:  2001-04       Impact factor: 9.043

5.  Characterization of a Novel Gene in the Extended MHC Region of Mouse, NG29/Cd320, a Homolog of the Human CD320.

Authors:  Hyo Jin Park; Ji-Yeon Kim; Kyung In Jung; Tae Jin Kim
Journal:  Immune Netw       Date:  2009-08-31       Impact factor: 6.303

6.  Comparative and evolutionary analysis of the rhesus macaque extended MHC class II region.

Authors:  Ralf Sudbrak; Richard Reinhardt; Steffen Hennig; Hans Lehrach; Eberhard Günther; Lutz Walter
Journal:  Immunogenetics       Date:  2002-12-10       Impact factor: 2.846

7.  Comparative genome organization of human, murine, and feline MHC class II region.

Authors:  Naoya Yuhki; Thomas Beck; Robert M Stephens; Yoko Nishigaki; Kymberly Newmann; Stephen J O'Brien
Journal:  Genome Res       Date:  2003-05-12       Impact factor: 9.043

Review 8.  The human Major Histocompatibility Complex as a paradigm in genomics research.

Authors:  Claire Vandiedonck; Julian C Knight
Journal:  Brief Funct Genomic Proteomic       Date:  2009-05-25

9.  Full-length sequence analysis of the HLA-DRB1 locus suggests a recent origin of alleles.

Authors:  Jenny von Salomé; Ulf Gyllensten; Tomas F Bergström
Journal:  Immunogenetics       Date:  2007-02-16       Impact factor: 2.846

Review 10.  Comparative genomics of major histocompatibility complexes.

Authors:  James Kelley; Lutz Walter; John Trowsdale
Journal:  Immunogenetics       Date:  2004-12-18       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.